Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US8816242098

SecurityTEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
InstitutionSei Investments Co
Latest Disclosed Ownership965,264 shares
Latest Disclosed Value $ 30,125,877
Sei Investments Co ownership in TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)

On February 13, 2026 - Sei Investments Co filed a 13F-HR form disclosing ownership of 965,264 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) (US:TEVA) valued at $30,125,889 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 903,869 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock). This represents a change in shares of 6.79% during the quarter. The current value of the position is $31,689,617 USD.

Sei Investments Co has a history of taking positions in derivatives of the underlying security (TEVA) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 965,264 61,395 6.79 30,126 65.00 0.0297
2025-11-13 2025-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 903,869 -59,958 -6.22 18,258 13.03 0.0196
2025-08-14 2025-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 963,827 13,061 1.37 16,154 10.54 0.0187
2025-05-14 2025-03-31 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 950,766 457,730 92.84 14,613 34.48 0.0188
2025-05-13 2025-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 493,847 811 10,867 0.0118
2025-02-11 2024-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 493,036 25,089 5.36 10,867 28.87 0.0140
2024-11-12 2024-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 467,947 23,566 5.30 8,432 16.77 0.0110
2024-08-13 2024-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 444,381 -12,941 -2.83 7,221 11.92 0.0102
2024-05-07 2024-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 457,322 4,000 0.88 6,453 36.35 0.0095
2024-02-14 2023-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 453,322 95,489 26.69 4,733 29.68 0.0076
2023-11-14 2023-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 357,833 357,833 3,650 0.0066
2022-11-14 2022-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -134,601 -100.00 0 -100.00
2022-08-15 2022-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 134,601 -131,339 -49.39 1,012 -59.49 0.0022
2022-05-13 2022-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 265,940 -243 -0.09 2,498 17.17 0.0050
2022-02-14 2021-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 266,183 92 0.03 2,132 -17.75 0.0040
2021-11-12 2021-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 266,091 0 0.00 2,592 -1.59 0.0054
2021-08-06 2021-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 266,091 266,091 2,634 0.0058
2019-08-14 2019-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -20,774 -100.00 0 -100.00
2019-05-15 2019-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 20,774 -157,669 -88.36 326 -91.52 0.0011
2019-02-13 2018-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 178,443 49 0.03 3,844 0.03 0.0137
2018-11-08 2018-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 178,394 16,153 9.96 3,843 -2.61 0.0139
2018-08-03 2018-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 162,241 34,305 26.81 3,946 80.43 0.0134
2018-05-11 2018-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 127,936 -546,069 -81.02 2,187 -82.88 0.0084
2018-02-08 2017-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 674,005 140,493 26.33 12,772 36.02 0.0444
2017-11-06 2017-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 533,512 -1,187,954 -69.01 9,390 -83.58 0.0334
2017-07-31 2017-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 1,721,466 875,789 103.56 57,188 110.73 0.2280
2017-05-05 2017-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 845,677 77,015 10.02 27,138 -2.61 0.1189
2017-02-02 2016-12-31 13F TEVA PHARMACEUTICAL INDS ADR 881624209 768,662 -63,798 -7.66 27,864 -27.25 0.1349
2016-11-04 2016-09-30 13F TEVA PHARMACEUTICAL INDS ADR 881624209 832,460 -59,214 -6.64 38,301 -14.48 0.1946
2016-08-11 2016-06-30 13F TEVA PHARMACEUTICAL INDS ADR 881624209 891,674 132,153 17.40 44,788 10.20 0.2686
2016-05-10 2016-03-31 13F/A-1 TEVA PHARMACEUTICAL INDS ADR 881624209 759,521 32,185 4.43 40,642 -14.87 0.2529
2016-02-03 2015-12-31 13F TEVA PHARMACEUTICAL INDS ADR 881624209 727,336 50,082 7.39 47,743 24.86 0.2910
2015-11-02 2015-09-30 13F/A-1 TEVA PHARMACEUTICAL INDS ADR 881624209 677,254 211,968 45.56 38,238 39.05 0.3510
2015-10-30 2015-09-30 13F TEVA PHARMACEUTICAL INDS ADR 881624209 677,254 38,239
2015-08-07 2015-06-30 13F/A-1 TESORO LOGISTICS PUT 881624209 0 -602,050 -100.00 0 -100.00
2015-08-07 2015-06-30 13F/A-1 TEVA PHARMACEUTICAL INDS ADR 881624209 465,286 -136,764 -22.72 27,499 -26.67 0.2486
2015-08-04 2015-06-30 13F TEVA PHARMACEUTICAL INDS ADR 881624209 465,286 -136,764 27,499 0.2486
2015-05-14 2015-03-31 13F/A-1 TEVA PHARMACEUTICAL INDS ADR 881624209 602,050 -1,465 -0.24 37,498 8.05 0.3256
2015-05-01 2015-03-31 13F TESORO LOGISTICS PUT 881624209 602,050 602,050 37,498 0.3256
2015-02-10 2014-12-31 13F TEVA PHARMACEUTICAL INDS ADR 881624209 603,515 603,515 34,705 0.3068
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2015-08-07 2015-06-30 13F/A TESORO LOGISTICS PUT 0 -100.00 0 -100.00 n/a n/a n/a
2015-05-01 2015-03-31 13F TESORO LOGISTICS PUT 602,050 37,498 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.